MSC-4106
CAS No. 2738542-58-8
MSC-4106( —— )
Catalog No. M35343 CAS No. 2738542-58-8
MSC-4106, an orally active and potent YAP/TAZ-TEAD inhibitor, disrupts TEAD1 and TEAD3 auto-palmitoylation and demonstrates significant efficacy in the NCI-H226 tumor xenograft model .
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 147 | Get Quote |
|
| 5MG | 235 | Get Quote |
|
| 10MG | 377 | Get Quote |
|
| 25MG | 610 | Get Quote |
|
| 50MG | 869 | Get Quote |
|
| 100MG | 1152 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameMSC-4106
-
NoteResearch use only, not for human use.
-
Brief DescriptionMSC-4106, an orally active and potent YAP/TAZ-TEAD inhibitor, disrupts TEAD1 and TEAD3 auto-palmitoylation and demonstrates significant efficacy in the NCI-H226 tumor xenograft model .
-
DescriptionMSC-4106 is an orally active and potent inhibitor of YAP/TAZ-TEAD. MSC-4106 inhibits TEAD1 or TEAD3 auto-palmitoylation and shows inhibitory effect on NCI-H226 tumor xenograft model.
-
In VitroMSC-4106 (10 μM, 24 h) inhibited SK-HEP-1 reporter and NCI-266 cell viability with IC50 values of 4 nM and 14 nM, respectively.MSC-4106 (10 μM, 6 h) crystallizes in the P-site of TEAD1, and against TEAD1 or TEAD3 palmitoylation in TEAD-Overexpressing HEK293 Cells by 97.3% and 75.9%, respectively.MSC-4106 (10 μM, 4 d) targets TEAD indicated by a reduction in viability of NCI-H226 cells.Cell Viability Assay Cell Line:NCI-H226 (YAP dependent); SW620 YAP/TAZ KO (Yap-independent) cells Concentration:0, 3, 6, 9, 12, 15, 18, 21, 24, 26, 30 μM Incubation Time:96 hours Result:Showed inhibitory effect to NCI-H226 and general cytotoxic to SW620 (IC50 >30 μM).Immunofluorescence Cell Line:SK-HEP-1Concentration:0, 3, 6, 9, 12, 15, 18, 21, 24, 26, 30 μM Incubation Time:24 hours Result:Inhibited YAP-TEAD interation.
-
In VivoMSC-4106 (100 mg/kg/d; p.o.; 7 d) displays anti-tumor effect with controlled tumor volume and good tolerability with stable body weight in mice.MSC-4106 (1, 5, 100 mg/kg/d; p.o.; 0-72 h) down-regulates Cyr61 (cysteine-rich angiogenic inducer 61) expression, the TEAD-regulated target gene, in tumor lysates at all time points at 100 mg/kg and 24 h at 5 mg/kg.Note: PO studies were performed at 10 mg/kg; MSC-4106 was formulated in 20% Kleptose in 50 mM PBS at pH 7.4.Animal Model:NCI-H226 xenograft model in H2d Rag2 female mice (9-week-old)Dosage:5, 100 mg/kg Administration:Oral gavage; once daily; 32 days Result:Resulted tumor growth controlled with 5 mg/kg while regressed with 100 mg/kg dosing after 32 treatment days.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorYAP
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2738542-58-8
-
Formula Weight359.3
-
Molecular FormulaC18H12F3N3O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 250 mg/mL (695.80 mM; Ultrasonic )
-
SMILESCn1cc2c3cc(ccc3n(-c3ccc(cc3)C(F)(F)F)c2n1)C(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Timo Heinrich, et al. Optimization of TEAD P-site binding fragment hit into in vivo active lead MSC-4106. J. Med. Chem. 2022, 65, 13, 9206–9229.?
molnova catalog
related products
-
Saikosaponin C
Saikosaponin C efficiently inhibited LPS-induced apoptotic cell death via inhibition of caspase-3 activation and caspase-3-mediated-FAK degradation.
-
Smurf1-IN-A01
Smurf1-IN-A01 is a ubiquitin ligase Smad ubiquitination regulatory factor-1 inhibitor (kd: 3.664 nM).
-
Protosappanin B
Protosappanin B significantly increases cell viability, inhibits cell apoptosis and up-regulates the expression of growth-associated protein 43.
Cart
sales@molnova.com